Post Profile






Pfizer set to start shipping Remicade biosimilar next month

(Reuters) - Pfizer Inc said on Monday it plans to begin shipping its biosimilar version of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade in late November at a 15 percent discount to current wholesale prices.
read more

share

Related Posts


FDA Approves Pfizer Pill For Rheumatoid Arthritis

Medical / Pharmaceutical : Pharmalot

After months of anticipation, the FDA approved a new rheumatoid arthritis pill from Pfizer that some Wall Streeters have been betting will become a blockbuster seller. Previously called tofacinitib, the drug has been re-named Xeljan...

New biologic drug for rheumatoid arthritis approved by the FDA

Health : Bel Marra Health

The FDA has recently approved a new biologic drug to treat rheumatoid arthritis and other inflammatory diseases. Known as Erelzi, the drug is a biosimilar for Enbrel, which was previously approved by the FDA. A biosimilar is a biolo...

India rejects patent on Pfizer's arthritis drug

Business & Finance : Business Insider: Clusterstock

MUMBAI (Reuters) - India has again denied Pfizer Inc a patent on its rheumatoid arthritis drug tofacitinib, the latest setback for a multinational drugmaker seeking to enforce its intellectual property rights in the country. Pfizer ...

A new drug that could save the US billions of dollars just got approved

Business & Finance : Business Insider: Clusterstock

The FDA just approved a version of Remicade, a drug used to treat autoimmune diseases like Crohn's disease and rheumatoid arthritis. The drug, which was developed by Celltrion and will be co-marketed by Pfizer, goes by the name Infl...

Samsung Bioepis receives final European approval for its Remicade copy

Business & Finance : Business Insider: Clusterstock

SEOUL (Reuters) - South Korea's Samsung Bioepis said on Monday its biosimilar of Johnson & Johnson's blockbuster rheumatoid arthritis drug Remicade has received final approval from European regulators, paving the way for its second ...

Comments


Copyright © 2016 Regator, LLC